Synthetic Biology in India: Issues in Risk, Power and Governance


37 Pages Posted: 8 Jan 2015

See all articles by Krishna Ravi Srinivas

Krishna Ravi Srinivas

Research Information System for Developing Countries (RIS)

Date Written: December 30, 2014


Synthetic biology is an emerging technology that can facilitate ‘design’ and ‘creation’ of micro-organisms which may not be found in nature. Synthetic biology is considered as an amalgamation of principles of engineering and biology. Globally synthetic biology has advanced rapidly in the last decade; however, in India it is in nascent stages. In this discussion paper, the status of synthetic biology in India and debates in India on synthetic biology are discussed and the discourses on synthetic biology in India are also analysed. While synthetic biology is yet to get a big push in India, initiatives on biofuels and setting up of research centers indicate that it can grow rapidly in India. The Task Force set up by the Planning Commission examined the various issues including regulatory issues and suggested a way forward for synthetic biology in India. The concerns about dual use, absence of governance structures and need for regulation are not unique to India. Given the potential of synthetic biology in biomedicine, agriculture, energy and other sectors it is important that synthetic biology gets the priority it deserves. The paper also examines the potential pathways for synthetic biology in India and points out that adequate support in terms of funding and addressing regulatory, ethical, legal and social issues is necessary to reap the benefits of synthetic biology.

Keywords: Synthetic biology, genetic engineering, DIY biology, dual use, India, governance, intellectual property rights, risk, ethics

Suggested Citation

Srinivas, Krishna Ravi, Synthetic Biology in India: Issues in Risk, Power and Governance (December 30, 2014). RIS DISCUSSION PAPER #194. Available at SSRN:

Krishna Ravi Srinivas (Contact Author)

Research Information System for Developing Countries (RIS) ( email )

Here is the Coronavirus
related research on SSRN

Paper statistics

Abstract Views
PlumX Metrics